Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18886244 | Oral Care Compositions Comprising Monodentate And Polydentate Ligand | September 2024 | June 2025 | Allow | 9 | 2 | 0 | Yes | No |
| 18382761 | CYCLOPENTANONE COMPOUNDS | October 2023 | December 2024 | Allow | 13 | 1 | 0 | No | No |
| 18368190 | FORMULATIONS OF CLOMAZONE | September 2023 | April 2025 | Abandon | 19 | 1 | 0 | No | No |
| 18446041 | VACCINE ADJUVANTS BASED ON TLR RECEPTOR LIGANDS | August 2023 | January 2024 | Allow | 5 | 1 | 0 | No | No |
| 18311704 | GOLD AND PALMITOYL PENTAPEPTIDE-4 NANOPARTICLES | May 2023 | April 2025 | Allow | 24 | 2 | 1 | No | No |
| 18295907 | USE OF APE1/REF-1 INHIBITORS FOR TREATMENT OF RETINAL DISEASES | April 2023 | March 2025 | Allow | 23 | 1 | 0 | No | No |
| 18115340 | MINERAL TREATMENT METHOD FOR DAMAGED TEETH | February 2023 | May 2023 | Allow | 3 | 0 | 0 | No | No |
| 18088448 | Peroxymonosulfate Oral Whitening Compositions | December 2022 | October 2024 | Allow | 21 | 2 | 0 | No | Yes |
| 18083133 | MOISTURIZER COMPOSITIONS AND METHODS OF MAKING THE SAME | December 2022 | March 2024 | Abandon | 15 | 1 | 0 | No | No |
| 18074608 | PERSONAL CARE COMPOSITIONS FOR CLEANSING THE SKIN | December 2022 | April 2025 | Allow | 28 | 3 | 1 | Yes | No |
| 17961785 | Oral Compositions | October 2022 | April 2025 | Allow | 30 | 2 | 0 | Yes | No |
| 17949833 | Sulfate-Free Surfactant System | September 2022 | June 2024 | Allow | 21 | 1 | 0 | No | No |
| 17944550 | Jammed Emulsion Toothpaste Compositions | September 2022 | June 2025 | Allow | 33 | 4 | 0 | No | No |
| 17942390 | TISSUE STAIN AND USE THEREOF | September 2022 | January 2025 | Allow | 28 | 2 | 1 | No | No |
| 17880300 | APPARATUS, METHODS AND SYSTEMS FOR LOW ENERGY PROCESSING OF CONSUMER PERSONAL HYGIENE PRODUCTS; FORMULATIONS OF THE SAME | August 2022 | November 2024 | Abandon | 27 | 1 | 1 | No | No |
| 17877907 | USE OF CANNABINOID COMPOUNDS IN ORAL CARE COMPOSITIONS TO INHIBIT THE GROWTH OF P. GINGIVALIS | July 2022 | December 2023 | Abandon | 17 | 0 | 1 | No | No |
| 17813636 | AGRICULTURAL PESTICIDE COMPOSITIONS | July 2022 | July 2024 | Allow | 23 | 2 | 0 | Yes | No |
| 17661276 | USE OF CANNABINOIDS IN THE TREATMENT OF ORAL INFLAMMATION AND PERIODONTAL DISEASE | April 2022 | December 2023 | Abandon | 20 | 0 | 1 | No | No |
| 17720164 | DENTAL WHITENING COMPOSITION | April 2022 | December 2023 | Abandon | 20 | 1 | 0 | No | No |
| 17656646 | ORAL CARE PRODUCT WITH CANNABINOID COMPOUNDS | March 2022 | December 2023 | Abandon | 21 | 0 | 1 | No | No |
| 17683687 | OPIOID INDEPENDENT SURGICAL ANESTHETIC | March 2022 | May 2025 | Allow | 39 | 3 | 1 | No | No |
| 17648612 | Dental Composition Comprising Potassium Nitrate and Propolis | January 2022 | April 2024 | Abandon | 27 | 2 | 0 | No | No |
| 17628715 | COMPLETE FOOD FOR AQUACULTURE ANIMALS FORMED FROM INSECT LARVAE | January 2022 | March 2025 | Abandon | 37 | 0 | 1 | No | No |
| 17550935 | SERIAL FILTRATION TO GENERATE SMALL CHOLESTEROL-CONTAINING LIPOSOMES | December 2021 | March 2025 | Allow | 39 | 2 | 0 | Yes | No |
| 17541835 | COMPOSITION HAVING EXCELLENT PHYSICAL PROPERTIES, BIOSTABILITY, AND EFFECTS OF REDUCING BACTERIAL ADHESION AND BIOFILM FORMATION AND OF AMPLIFYING SOD ACTIVITY, FOR ORTHODONTIC CORRECTION AND PREVENTION AND TREATMENT OF DENTAL DISEASES | December 2021 | September 2023 | Abandon | 21 | 1 | 0 | No | No |
| 17614548 | USE OF MAGNESIUM HYDRIDE IN PREPARATION OF COMPOSITION FOR PREVENTING AND TREATING CHRONIC PERIODONTITIS, AND MAGNESIUM HYDRIDE TOOTHPASTE | November 2021 | August 2024 | Allow | 33 | 0 | 1 | No | No |
| 17610258 | CONTROLLED RELEASE DEVICE FOR ORAL CAVITY | November 2021 | April 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17452216 | COSMETIC MICRONEEDLE | October 2021 | October 2024 | Abandon | 36 | 2 | 0 | No | No |
| 17497301 | NHAP CONTAINING ORAL COMPOSITION | October 2021 | August 2023 | Allow | 22 | 1 | 1 | Yes | No |
| 17490377 | INFLAMMATION REDUCING COMPOSITION CONTAINING A CANNABIS SATIVA COMPOUND | September 2021 | June 2023 | Abandon | 20 | 1 | 0 | No | No |
| 17482721 | Oral Care Substance Delivery Device and Method of Manufacture | September 2021 | June 2023 | Abandon | 20 | 0 | 1 | No | No |
| 17471888 | DISSOLVABLE SOLID ARTICLE CONTAINING ANTI-BACTERIAL ACTIVES | September 2021 | September 2023 | Allow | 25 | 2 | 0 | Yes | No |
| 17468858 | Graffiti Removal System | September 2021 | April 2023 | Allow | 19 | 1 | 0 | No | No |
| 17404754 | TEETH CLEANING AND REMINERALIZING TOOTHPASTES | August 2021 | April 2024 | Abandon | 32 | 2 | 0 | Yes | No |
| 17399000 | INK FORMULATION AND MANUFACTURE THEREOF | August 2021 | December 2024 | Abandon | 40 | 2 | 1 | No | No |
| 17383934 | Oral Care Compositions Containing Sodium Lauroyl Sarcosinate and Betaine | July 2021 | September 2024 | Allow | 38 | 3 | 0 | Yes | No |
| 17372373 | BRANCHED AMINO ACID SURFACTANTS FOR PERSONAL CARE AND COSMETIC PRODUCTS | July 2021 | November 2024 | Allow | 40 | 4 | 1 | No | No |
| 17359026 | Oral Care Compositions | June 2021 | July 2023 | Allow | 24 | 2 | 0 | No | No |
| 17417305 | COMPOSITION FOR ORAL CAVITY | June 2021 | June 2023 | Allow | 24 | 2 | 0 | No | No |
| 17303780 | ORAL CARE PRODUCT FORMULATION | June 2021 | September 2022 | Allow | 16 | 0 | 0 | No | No |
| 17308081 | Oral Care Compositions Comprising Monodentate And Polydentate Ligand | May 2021 | February 2025 | Abandon | 45 | 3 | 0 | No | No |
| 17245330 | Mouthwash For Oral Care Benefits | April 2021 | June 2024 | Allow | 38 | 4 | 0 | No | No |
| 17245179 | Oral Powder Mixture With Small Sized Particles | April 2021 | January 2025 | Allow | 45 | 6 | 0 | No | No |
| 17287560 | FOAMABLE DENTAL CARE COMPOSITION, SYSTEM CONSISTING OF THE DENTAL CARE COMPOSITION AND A DISPENSER, AND USE OF THE DENTAL CARE COMPOSITION IN A METHOD FOR SIMULTANEOUSLY CLEANING SEVERAL, PREFERABLY ALL, TEETH | April 2021 | November 2023 | Abandon | 31 | 1 | 1 | No | No |
| 17234241 | REMINERALIZATION OF TEETH USING BRAZILIAN GREEN PROPOLIS | April 2021 | January 2023 | Allow | 20 | 1 | 0 | Yes | No |
| 17286390 | COSMETIC TENSIONING COMPOSITION | April 2021 | January 2025 | Abandon | 45 | 5 | 0 | No | No |
| 17273661 | GLASS COMPOSITION | March 2021 | April 2024 | Allow | 38 | 3 | 0 | No | No |
| 17172103 | ABSORBABLE BONE WAX HAVING FUNCTION OF PROMOTING BONE REPAIR AND PREPARATION METHOD THEREOF | February 2021 | September 2024 | Allow | 43 | 2 | 0 | No | No |
| 17267806 | A biphasic hydrogel formulation and methods of production and use thereof | February 2021 | May 2024 | Abandon | 40 | 0 | 1 | No | No |
| 17264877 | SUNSCREEN COMPOSITION, USE OF THE SUNSCREEN COMPOSITION AND PROCESS OF MANUFACTURING THE SUNSCREEN COMPOSITION | February 2021 | June 2023 | Abandon | 28 | 2 | 0 | No | No |
| 17146935 | METHODS AND COMPOSITIONS FOR FLUID DRAINAGE BY PIEZO ION CHANNEL ACTIVATION | January 2021 | August 2024 | Allow | 43 | 3 | 0 | No | No |
| 17251009 | FOAMING COMPOSITION | December 2020 | August 2024 | Allow | 45 | 4 | 0 | No | No |
| 17251108 | METHOD FOR APPLYING FALSE EYELASHES AND MAKEUP METHOD | December 2020 | July 2023 | Allow | 31 | 2 | 0 | No | No |
| 16972465 | NOVEL SELF-ASSEMBLED AMINO ACID SUPRAMOLECULAR POLYMER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | December 2020 | August 2022 | Allow | 21 | 1 | 1 | No | No |
| 16972461 | SELF-ASSEMBLED AMINO ACID SUPRAMOLECULAR POLYMER, PREPARATION THEREFOR, AND APPLICATION THEREOF | December 2020 | September 2022 | Allow | 21 | 1 | 1 | Yes | No |
| 15734687 | CYCLOPENTANONE COMPOUNDS | December 2020 | August 2023 | Allow | 33 | 3 | 0 | Yes | No |
| 17105748 | Antimicrobial Dental Gel | November 2020 | June 2023 | Abandon | 30 | 0 | 0 | No | No |
| 17072318 | SULFATE-FREE SURFACTANT SYSTEM | October 2020 | July 2022 | Allow | 21 | 0 | 0 | No | No |
| 17067650 | Fluoride-free Oral Care Composition | October 2020 | January 2023 | Abandon | 27 | 1 | 0 | Yes | No |
| 17046504 | Disintegrating Oral Tablet Suitable For Active Pharmaceutical Ingredients | October 2020 | January 2025 | Abandon | 51 | 5 | 0 | No | No |
| 17039185 | Tablet Dosage Form For Buccal Absorption Of Active Ingredients | October 2020 | August 2024 | Allow | 47 | 4 | 0 | No | No |
| 17042500 | GOLD AND PALMITOYL PENTAPEPTIDE-4 NANOPARTICLES | September 2020 | May 2023 | Abandon | 32 | 2 | 1 | No | No |
| 17042606 | WATER-IN-OIL EMULSION COSMETIC | September 2020 | July 2023 | Allow | 33 | 3 | 0 | Yes | No |
| 17040143 | USE OF A DRY FILM FOR COSMETIC TOPICAL APPLICATIONS | September 2020 | August 2024 | Allow | 47 | 4 | 0 | Yes | No |
| 17026671 | USE OF APE1/REF-1 INHIBITORS FOR TREATMENT OF RETINAL DISEASES | September 2020 | January 2023 | Allow | 27 | 2 | 0 | Yes | No |
| 17005452 | COSMETIC COMPOSITION AND ITS USE, DERMOCOSMETIC FORMULATION | August 2020 | August 2022 | Allow | 24 | 1 | 0 | No | No |
| 17003765 | ANTIMICROBIAL GALLIUM COMPOUNDS AND METHODS | August 2020 | November 2022 | Allow | 27 | 1 | 0 | Yes | No |
| 16996119 | APPARATUS, METHODS AND SYSTEMS FOR LOW ENERGY PROCESSING OF CONSUMER PERSONAL HYGIENE PRODUCTS; FORMULATIONS OF THE SAME | August 2020 | August 2022 | Abandon | 24 | 1 | 1 | No | No |
| 16768459 | COSMETIC COMPOSITION FOR IMMEDIATE WRINKLE IMPROVEMENT AND ELASTICITY ENHANCEMENT | May 2020 | October 2022 | Abandon | 28 | 1 | 1 | No | No |
| 16617272 | AQUEOUS MICROEMULSION | November 2019 | July 2022 | Allow | 32 | 2 | 1 | No | No |
| 16600066 | METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE | October 2019 | April 2024 | Allow | 54 | 6 | 1 | Yes | No |
| 16319673 | COSMETIC PRODUCT INCLUDING COSMETIC CONTAINER USING SPECIFIC RUBBER | January 2019 | June 2022 | Abandon | 41 | 0 | 1 | No | No |
| 16099808 | AQUEOUS AGRICULTURAL COMPOSITION HAVING IMPROVED SPRAY DRIFT PERFORMANCE | November 2018 | April 2022 | Allow | 41 | 3 | 1 | No | No |
| 16080823 | BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE | August 2018 | December 2022 | Allow | 51 | 4 | 1 | Yes | Yes |
| 16077008 | WATER-IN-OIL MICROEMULSIONS FOR PERSONAL CARE | August 2018 | December 2021 | Allow | 40 | 4 | 1 | Yes | No |
| 15764366 | POLYMER CONJUGATE VACCINES | March 2018 | June 2022 | Allow | 51 | 4 | 2 | No | No |
| 15736865 | INJECTABLE PHARMACEUTICAL FORMULATIONS OF LEFAMULIN | December 2017 | June 2024 | Allow | 60 | 6 | 1 | Yes | Yes |
| 15572746 | OIL-IN-WATER TYPE EMULSION COMPOSITION AND METHOD FOR PRODUCING SAME | November 2017 | December 2022 | Abandon | 60 | 5 | 1 | No | No |
| 15690178 | TISSUE STAIN AND USE THEREOF | August 2017 | August 2022 | Allow | 60 | 5 | 1 | No | No |
| 15414771 | AGRICULTURAL PESTICIDE COMPOSITIONS | January 2017 | April 2022 | Allow | 60 | 5 | 1 | No | No |
| 14912546 | METHOD FOR PRODUCING MICROPARTICLES | February 2016 | November 2022 | Abandon | 60 | 7 | 1 | No | No |
| 15004338 | FORMULATIONS OF CLOMAZONE | January 2016 | May 2018 | Abandon | 28 | 10 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PETRITSCH, AMANDA MICHELLE.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner PETRITSCH, AMANDA MICHELLE works in Art Unit 1612 and has examined 81 patent applications in our dataset. With an allowance rate of 61.7%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 30 months.
Examiner PETRITSCH, AMANDA MICHELLE's allowance rate of 61.7% places them in the 15% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by PETRITSCH, AMANDA MICHELLE receive 2.26 office actions before reaching final disposition. This places the examiner in the 77% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by PETRITSCH, AMANDA MICHELLE is 30 months. This places the examiner in the 39% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +37.5% benefit to allowance rate for applications examined by PETRITSCH, AMANDA MICHELLE. This interview benefit is in the 87% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 25.7% of applications are subsequently allowed. This success rate is in the 31% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 25.9% of cases where such amendments are filed. This entry rate is in the 27% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 68% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 84% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 106.7% are granted (fully or in part). This grant rate is in the 98% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.